Ten children with locally advanced or recurrent tumors were treated on a Phase 1/11 study to assess the feasibility and toxicity of intraoperative radiotherapy (IORT) for primary and recurrent pediatric solid malignancies at high risk for local recurrence. Eligible patients include all primary and r
Retreatment of pediatric brain tumors with radiation and misonidazole: Results of a CCSG/RTOG phase I/II study
โ Scribed by William M. Wara; Kent E. Wallner; Victor A. Levin; Hsiu-Chih Liu; Michael S. B. Edwards
- Publisher
- John Wiley and Sons
- Year
- 1986
- Tongue
- English
- Weight
- 568 KB
- Volume
- 58
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract ## BACKGROUND Fotemustine is a nitrosourea with theoretic and preclinical advantages over the original analogs, carmustine and lomustine, in the treatment of brain tumors. This is the first pediatric Phase I study of fotemustine. ## METHODS Patients younger than 21 with recurrent/res
## Background: The prognosis of children with high-grade astrocytomas of the central nervous system is grim and has not been substantially improved by conventional chemoradiotherapy. we performed a multi-institutional phase i study to determine the toxicities and tolerance of concurrent external be